Hemostatic Measures During Laparoscopic Cystectomy for Endometrioma
Launched by AIN SHAMS MATERNITY HOSPITAL · May 15, 2024
Trial Information
Current as of March 14, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • 18 to 35 years
- • unilateral endometriotic cyst
- Exclusion Criteria:
- • anovulatory women women with decreased ovarian reserve women receiving hormonal treatment three months prior to surgery women with any contraindication to laparoscopy women with previous ovarian surgery possible ovarian malignancy.
Trial Officials
Osama Kamel, MD
Study Director
Ain Shams University
About Ain Shams Maternity Hospital
Ain Shams Maternity Hospital is a leading healthcare institution dedicated to providing comprehensive maternal and neonatal care. With a commitment to advancing women's health, the hospital engages in innovative clinical research and trials aimed at improving treatment outcomes and enhancing patient care. Equipped with state-of-the-art facilities and a team of experienced healthcare professionals, Ain Shams Maternity Hospital fosters a collaborative environment for research that prioritizes safety, efficacy, and ethical standards. Through its clinical trials, the hospital seeks to contribute to the global body of knowledge in obstetrics and gynecology, ultimately benefiting patients and healthcare providers alike.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Cairo, , Egypt
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0
Related articles
